Cardiovascular risk factors in the elderly

E Casiglia1, P Palatini

  • 1Department of Clinical and Experimental Medicine, Clinica Medica 1, University of Padova, Italy.

Insights

Cardiovascular risk factors differ in older adults. "Minor" indicators like serum uric acid strongly predict mortality, unlike typical "major" factors such as blood pressure in the elderly.

Area of Science:

  • Gerontology
  • Cardiology
  • Epidemiology

Background:

  • Established cardiovascular risk factors are well-documented in younger populations.
  • Data on cardiovascular disease risk factors in the elderly are scarce and their predictive value is less understood.
  • Older adults exhibit a distinct risk profile compared to younger individuals.

Purpose of the Study:

  • To investigate the prevalence and importance of cardiovascular risk factors in the elderly.
  • To identify reliable predictors of cardiovascular morbidity and mortality in older populations.
  • To inform clinical practice regarding cardiovascular risk assessment in geriatric patients.

Main Methods:

  • Review of existing literature on cardiovascular risk factors in elderly populations.
  • Analysis of epidemiological data focusing on geriatric cohorts.
  • Comparison of the predictive value of traditional versus non-traditional risk factors for cardiovascular outcomes in the elderly.

Main Results:

  • Traditional major risk factors like blood pressure and total cholesterol show diminished predictive power for cardiovascular mortality in the elderly, particularly at advanced ages.
  • Factors often considered 'minor' in younger individuals, such as serum uric acid, ventilatory function, and proteinuria, demonstrate significant predictive value for cardiovascular mortality in older adults.
  • Left ventricular hypertrophy's role as a predictor of cardiovascular mortality is less clear in the elderly compared to younger cohorts.

Conclusions:

  • Cardiovascular risk assessment in the elderly requires a shift in focus from traditional risk factors to indicators like serum uric acid, ventilatory function, and proteinuria.
  • Recognizing the distinct risk profiles in older adults is crucial to prevent overtreatment of conditions like mildly elevated blood pressure or cholesterol.
  • Future research should validate these findings and explore the underlying mechanisms driving these age-specific risk factor associations.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...